###begin article-title 0
PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism
###end article-title 0
###begin p 1
###xml 159 162 159 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 172 174 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
Peroxisome proliferator activated receptor gamma 2 (PPARg2) is the nutritionally regulated isoform of PPARg. Ablation of PPARg2 in the ob/ob background, PPARg2-/- Lepob/Lepob (POKO mouse), resulted in decreased fat mass, severe insulin resistance, beta-cell failure, and dyslipidaemia. Our results indicate that the PPARg2 isoform plays an important role, mediating adipose tissue expansion in response to positive energy balance. Lipidomic analyses suggest that PPARg2 plays an important antilipotoxic role when induced ectopically in liver and muscle by facilitating deposition of fat as relatively harmless triacylglycerol species and thus preventing accumulation of reactive lipid species. Our data also indicate that PPARg2 may be required for the beta-cell hypertrophic adaptive response to insulin resistance. In summary, the PPARg2 isoform prevents lipotoxicity by (a) promoting adipose tissue expansion, (b) increasing the lipid-buffering capacity of peripheral organs, and (c) facilitating the adaptive proliferative response of beta-cells to insulin resistance.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 159 165 <span type="species:ncbi:9606">people</span>
###xml 207 213 <span type="species:ncbi:9606">people</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 781 786 <span type="species:ncbi:10090">mouse</span>
###xml 882 887 <span type="species:ncbi:10090">mouse</span>
###xml 930 935 <span type="species:ncbi:10090">mouse</span>
It is known that obesity is linked to type 2 diabetes, however how obesity causes insulin resistance and diabetes is not well understood. Some extremely obese people are not diabetic, while other less obese people develop severe insulin resistance and diabetes. We believe diabetes occurs when adipose tissue becomes "full," and fat overflows into other organs such as liver, pancreas, and muscle, causing insulin resistance and diabetes. Peroxisome proliferator activated receptor gamma (PPARg) is essential for the development of adipose tissue and control of insulin sensitivity. PPARg2 is the isoform of PPARg regulated by nutrition. Here we investigate the role of PPARg2 under conditions of excess nutrients by removing the PPARg2 isoform in genetically obese mice, the POKO mouse. We report that removing PPARg2 decreases adipose tissue's capacity to expand and prevents the mouse from making as much fat as a normal obese mouse, despite eating similarly. Our studies suggest that PPARg plays an important antitoxic role when it is induced in liver, muscle, and beta cells by facilitating deposition of fat as relatively harmless lipids and thus prevents accumulation of toxic lipid species. We also show that PPARg2 may be involved in the adaptive response of beta cells to insulin resistance.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b001">1</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 273 279 <span type="species:ncbi:9606">people</span>
An adipocentric view of the Metabolic Syndrome (MS) considers obesity as the major factor leading to insulin resistance in peripheral metabolic tissues. However, the link between obesity and insulin resistance is complex, as indicated by the fact that some extremely obese people are glucose tolerant, while others with a mild degree of obesity develop severe insulin resistance and diabetes. This suggests that the absolute amount of fat stored may not be the most important factor determining the relationship between obesity and insulin resistance. Recent work showing the complexity of the molecular mechanisms controlling adipogenesis [1,2] suggests that adipose tissue expandability may be an important factor linking obesity, insulin resistance, and associated comorbidities.
###end p 6
###begin p 7
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b003">3</xref>
###xml 431 432 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b004">4</xref>
###xml 663 664 663 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b005">5</xref>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b008">8</xref>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b009">9</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b011">11</xref>
There are two mechanisms that have been proposed to explain how expansion of the adipose tissue stores affects insulin sensitivity. One mechanism suggests that increased adiposity induces a chronic inflammatory state characterized by increased cytokine production by adipocytes and/or from macrophages infiltrating adipose tissue. Cytokines produced by these adipocytes or macrophages may directly antagonise insulin signalling [3,4]. A second nonexclusive hypothesis is lipotoxicity. The lipotoxic hypothesis states that if the amount of fuel entering a tissue exceeds its oxidative or storage capacity, toxic metabolites that inhibit insulin action are formed [5-8]. Of particular relevance to this article, lipid metabolites, such as ceramides and diacylglycerol (DAG) or reactive oxygen species generated from hyperactive oxidative pathways, have been shown to inhibit insulin signalling and to induce apoptosis [9-11].
###end p 7
###begin p 8
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b012">12</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b015">15</xref>
###xml 381 383 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b016">16</xref>
###xml 515 517 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b016">16</xref>
###xml 518 520 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b017">17</xref>
###xml 704 706 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b017">17</xref>
###xml 707 709 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b020">20</xref>
###xml 931 932 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 933 935 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b018">18</xref>
###xml 1269 1270 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 1271 1273 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b013">13</xref>
###xml 1274 1276 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b021">21</xref>
###xml 1277 1279 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b022">22</xref>
###xml 1558 1560 1555 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b023">23</xref>
###xml 1561 1563 1558 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b024">24</xref>
###xml 1719 1721 1716 1718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b025">25</xref>
###xml 1722 1724 1719 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b026">26</xref>
###xml 1850 1852 1844 1846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b027">27</xref>
###xml 1853 1855 1847 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b029">29</xref>
###xml 2193 2195 2175 2177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b030">30</xref>
###xml 2378 2380 2360 2362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b031">31</xref>
###xml 2090 2094 <span type="species:ncbi:10090">mice</span>
###xml 2265 2269 <span type="species:ncbi:10090">mice</span>
The nuclear receptor peroxisome proliferator activated receptor gamma (PPARg) is critically required for adipogenesis and insulin sensitivity [12-15]. There are two PPARg isoforms, PPARg1 and PPARg2. PPARg1 is expressed in many tissues and cell types, including white and brown adipose tissue, skeletal muscle, liver, pancreatic beta-cells, macrophages, colon, bone, and placenta [16]. Under physiological conditions, expression of PPARg2, the other splice variant, is restricted to white and brown adipose tissue [16,17]. In adipose tissue PPARg is the key regulator of adipogenesis. PPARg2 is the more adipogenic PPARg isoform in vitro, it is also the isoform regulated transcriptionally by nutrition [17-20]. Although under physiological conditions expression of PPARg2 is limited to adipose tissues, we have shown that PPARg2 is ectopically induced in liver and skeletal muscle in response to overnutrition or genetic obesity [2,18]. De novo expression of PPARg2 in liver and muscle in obesity suggests that PPARg2 may have a role in insulin resistance and lipotoxicity in these tissues. Little in vivo research into the metabolic roles for the specific isoforms of PPARg has been carried out, with the studies so far focusing almost exclusively on adipose tissue [2,13,21,22]. PPARg (both isoforms) deletions have been generated in most major metabolic tissues. Liver-specific deletion of both PPARg isoforms caused an impairment in insulin sensitivity, particularly when challenged by different genetic backgrounds (lipoatrophic or leptin-deficiency) [23,24]. The effect of ablating both PPARg isoforms in muscle produced controversial results, with two groups reporting different effects on insulin sensitivity [25,26]. The role of PPARg in pancreatic beta-cells is unclear, primarily due to its low expression under physiological conditions [27-29] and secondly because ablation of both PPARg isoforms in beta-cells did not result in a metabolic phenotype. However PPARg may play a role in beta-cell hyperplasia in response to insulin resistance, an idea supported by the fact that mice that lack PPARg in beta-cells do not expand their beta-cells mass in response to a high-fat diet [30]. More recently, it has been shown that heterozygous PPARg-deficient mice develop impaired insulin secretion, which is associated with increased islet triacylglycerol (TAG) content [31].
###end p 8
###begin p 9
###xml 130 134 <span type="species:ncbi:10090">mice</span>
Here we investigate the physiological relevance of PPARg2 under conditions of positive energy balance by ablating PPARg2 in ob/ob mice. We use a new approach that integrates traditional physiological phenotyping with advanced lipidomic technology and transcriptomics. Our results indicate that in the context of positive energy balance, the absence of PPARg2 results in a major metabolic failure. Furthermore, we provide evidence that control of adipose tissue expansion by PPARg2 may be an important variable linking positive energy balance to its metabolic complications including insulin resistance, beta-cell failure, and dyslipidaemia. Similarly, our lipidomic results indicate that induction of PPARg2 in nonadipose tissues should be considered as a physiological adaptation that prevents the toxic effects produced by excess nutrients. This antilipotoxic effect of PPARg2 is achieved by increasing the lipid-buffering capacity of peripheral organs and facilitating beta-cell hyperplasia in response to insulin resistance.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 28 32 <span type="species:ncbi:10090">Mice</span>
###xml 39 44 <span type="species:ncbi:10090">Mouse</span>
Ablation of PPARg2 in Ob/Ob Mice (POKO Mouse) Prevents Adipose Tissue Expansion in Response to Positive Energy Balance
###end title 11
###begin p 12
###xml 6 9 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 13 15 13 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 166 167 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 463 472 463 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg001">Figure S1</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
PPARg2-/- Lepob/Lepob mice with genetic ablation of the PPARg2 isoform on the obese hyperphagic ob/ob background (POKO) were generated. Matings of PPARg2+/- Lepob/Lep+ mice followed the expected Mendelian distribution (Fisher's test = 0.074 and 0.135 for males and females, respectively). PPARg1 gene expression in white adipose tissue (WAT) from five-week-old POKO mice was similar to PPARg2 KO mice and was not significantly different from wild-type (WT) mice (Figure S1).
###end p 12
###begin p 13
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g001">Figure 1</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
Figure 1A shows growth curves for male and female mice of four genotypes (WT, PPARg2 KO, ob/ob, and POKO mice) over a 12-week period. At birth, the body weight of male and female POKO mice was indistinguishable from other genotypes (unpublished data). The ob/ob mice quickly became heavier than their WT littermates, with significantly elevated body weight by four and six weeks of age in female and male mice, respectively. However, the POKO mice did not become obese, and their body weight remained close to WT and PPARg2 KO body weights mice during the 12-week study.
###end p 13
###begin p 14
###xml 31 39 31 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g001">Figure 1</xref>
###xml 164 165 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 200 201 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 217 226 213 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg002">Figure S2</xref>
###xml 282 290 278 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g001">Figure 1</xref>
###xml 748 757 744 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg002">Figure S2</xref>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
POKO mice were as hyperphagic (Figure 1B) as the ob/ob mice but drank far more water compared with ob/ob littermates (81.85 +/- 15.14 versus 9.05 +/- 2.32 ml/70 h, p < 0.01, female POKO versus ob/ob, n = 4 at 20 wk) (Figure S2A). Dual-energy X-ray absorptiometry analysis at 20 wk (Figure 1C) confirmed that female POKO mice had slightly increased fat content (4%) compared to WT and PPARg2 KO mice, but significantly reduced fat mass compared to the 40% increase observed in ob/ob mice. At the age of 20 wk, POKO and ob/ob mice had a trend to a decreased total locomotor activity during dark and light cycles compared with the WT and PPARg2 KO mice over the 72-h period. However POKO had similar total locomotor activity compared with ob/ob mice (Figure S2B).
###end p 14
###begin p 15
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 149 153 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0.75</sup>
###xml 159 160 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 187 188 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 280 281 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 432 433 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 595 596 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 791 792 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1070 1079 1046 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg002">Figure S2</xref>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
At six weeks of age, female POKO mice consumed a similar amount of oxygen as ob/ob mice (vO2 = 25.06 +/- 0.89 versus 23.10 +/- 0.99 ml/kg bodyweight 0.75/min, p = 0.07 POKO versus ob/ob, n = 6-8) showing a lower respiratory exchange ratio (0.916 +/- 0.011 versus 0.952 +/- 0.007, p = 0.01, female POKO versus ob/ob) in the fed state, but similar respiratory exchange ratio in the fasted state (0.73 +/- 0.014 versus 0.75 +/- 0.018, p-value = 0.59 POKO versus ob/ob mice). Water intake was already significantly increased in POKO compared to ob/ob mice (13.59 +/- 1.88 versus 8.15 +/- 0.89 ml/d, p-value < 0.05, POKO versus ob/ob). Furthermore, levels of glucose in urine were higher in POKO mice compared with ob/ob mice (403.4 +/- 49.2 versus 34.13 +/- 13.5 mMol/l, POKO versus ob/ob mice, p-value = 0.001), showing an energy loss of 15.43 +/- 3.06 kJ/d through urine compared with 0.70 +/- 0.19 kJ/d in ob/ob mice. At this age, POKO mice showed similar locomotor activity compared with the ob/ob mice during the day, but increased locomotor activity during the night (Figure S2C).
###end p 15
###begin p 16
###xml 142 150 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g001">Figure 1</xref>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g001">1</xref>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Histomorphometric analysis of adipose tissue from 16-wk-old male mice revealed that POKO mice had fewer small adipocytes than the ob/ob mice (Figure 1D and 1E). This analysis of adipocyte size suggests that ablation of PPARg2 in the ob/ob background impairs the potential for adipocyte recruitment.
###end p 16
###begin title 17
###xml 33 37 <span type="species:ncbi:10090">Mice</span>
Early Insulin Resistance in POKO Mice Independent of Body Weight
###end title 17
###begin p 18
###xml 250 257 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030064-t001">Table 1</xref>
###xml 711 719 711 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g002">Figure 2</xref>
###xml 991 998 991 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030064-t001">Table 1</xref>
###xml 1121 1129 1121 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g002">Figure 2</xref>
###xml 1357 1366 1357 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg003">Figure S3</xref>
###xml 1487 1494 1487 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030064-t001">Table 1</xref>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1115 1119 <span type="species:ncbi:10090">mice</span>
###xml 1351 1355 <span type="species:ncbi:10090">mice</span>
###xml 1409 1413 <span type="species:ncbi:10090">mice</span>
As expected the reduced adipose tissue expandability of the POKO mouse was associated with severe insulin resistance. Surprisingly insulin resistance developed very early in life with elevated insulin levels and blood glucose compared to ob/ob mice (Table 1). We investigated whether peripheral insulin resistance and/or a severe defect in insulin secretion may cause hyperglycaemia in the POKO mouse. No differences in plasma glucose levels were detected three to five days after birth amongst the four genotypes for both genders (unpublished data). At weaning (three weeks of age) total body weight was indistinguishable amongst the four genotypes, and blood glucose levels were similar in males and females (Figure 2A). However, by the age of four weeks, coincident with the change to a chow diet, male and female POKO mice developed severe hyperglycaemia compared to the other genotypes. Insulin plasma levels in the POKO mice at four weeks of age were increased compared to ob/ob mice (Table 1). Insulin resistance in POKO mice was confirmed by an insulin tolerance test (ITT) in four-week-old male and female mice (Figure 2B). Furthermore insulin resistance in adipose tissue was demonstrated by the extremely low levels of glucose transporter4 (GLUT4) protein in POKO adipose tissue when compared with GLUT4 levels in adipose tissue from ob/ob mice (Figure S3). Of note, insulin resistance in the POKO mice was associated with hypertriglyceridaemia as early as four-weeks of age (Table 1).
###end p 18
###begin title 19
###xml 11 15 <span type="species:ncbi:10090">Mice</span>
Adult POKO Mice are Hyperglycaemic and Have Low Plasma Insulin Levels
###end title 19
###begin p 20
###xml 326 333 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030064-t002">Table 2</xref>
###xml 524 531 524 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030064-t002">Table 2</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
Given the early insulin resistance and hyperinsulinaemia in the young POKO mice, we expected to see increased insulin levels in mature POKO mice. At 16 weeks, male POKO mice exhibited severe hyperglycaemia in the fasted and fed states compared to littermate controls. Male POKO mice had inappropriately low levels of insulin (Table 2). A similar, but milder phenotype was also observed in POKO female mice (unpublished data). Of note, adult ob/ob mice compensated for their insulin resistance with increased insulin levels (Table 2). POKO mice also had hypertriglyceridaemia when compared to WT, ob/ob, or PPARg2 KO mice.
###end p 20
###begin title 21
###xml 40 44 <span type="species:ncbi:10090">Mice</span>
Impaired Beta-Cell Function in the POKO Mice
###end title 21
###begin p 22
###xml 217 225 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g003">Figure 3</xref>
###xml 704 705 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 852 853 836 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 901 902 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1030 1038 1012 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g003">Figure 3</xref>
###xml 1313 1321 1288 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g003">Figure 3</xref>
###xml 1734 1740 1699 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut2,</italic>
###xml 1821 1830 1786 1795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg004">Figure S4</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 752 756 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
###xml 1307 1311 <span type="species:ncbi:10090">mice</span>
###xml 1342 1346 <span type="species:ncbi:10090">mice</span>
###xml 1434 1438 <span type="species:ncbi:10090">mice</span>
###xml 1634 1638 <span type="species:ncbi:10090">mice</span>
###xml 1773 1777 <span type="species:ncbi:10090">mice</span>
The inappropriately low insulin levels in the adult POKO mice suggested a defect in beta-cells. Insulin resistance in ob/ob mice was compensated for by increasing pancreatic insulin secretion, islet number, and size (Figure 3A). However, despite being more insulin resistant than ob/ob mice, POKO mice did not increase their beta-cell mass, resulting in lower plasma insulin levels than the ob/ob controls. Morphometric analysis of pancreatic sections from 16-week-old male mice confirmed that the islet-to-pancreas volume ratios were similar in the POKO, WT, and PPARg2 KO mice (0.023 +/- 0.005, 0.013 +/- 0.006, and 0.016 +/- 0.005, respectively) and markedly increased in ob/ob mice (0.077 +/- 0.017, p < 0.01 ob/ob versus POKO). Additionally, POKO mice had significantly decreased islet number and size (average area of islets POKO = 18.40 +/- 2 mm2) compared to ob/ob mice (ob/ob = 61.59 +/- 8 mm2). Insulin staining demonstrated that islets from POKO mice contained fewer insulin-positive cells than islets from ob/ob mice (Figure 3A). The normal cellular organization of the islet, abundant beta-cells (insulin staining) in the centre of the islet and a rim of alpha-cells at the periphery (glucagon staining), was retained in the insulin resistant ob/ob mice but was disrupted in the islets of POKO mice (Figure 3A). Islets from POKO mice had decreased number of insulin positive beta-cells when compared to islets from ob/ob mice and a scattered pattern of alpha-cells, which are morphological changes associated with islet remodelling in the context of beta-cell failure. Gene expression analysis of islets from 16-week-old mice revealed decreased expression of pancreatic duodenal homeobox-1, insulin receptor substrate 2, Glut2, and insulin in islets from POKO mice when compared with those from WT or ob/ob (Figure S4).
###end p 22
###begin p 23
###xml 250 258 244 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g002">Figure 2</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
The changes seen in the beta-cells of POKO mice were not the result of an inherent failure of the beta-cell to develop properly as indicated by histological studies of neonatal pancreas (day 3 to day 5) (unpublished data) and four-week-old pancreas (Figure 2C), showing no morphological differences in the size, number, or insulin staining of islets from POKO mice when compared to ob/ob controls.
###end p 23
###begin title 24
###xml 54 59 <span type="species:ncbi:10090">Mouse</span>
Impaired Glucose-Stimulated Insulin Secretion in POKO Mouse Islets
###end title 24
###begin p 25
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
We measured glucose-stimulated insulin secretion in 16-week-old female POKO mice and their ob/ob littermates. Islets isolated from POKO mice were 30% smaller than those from ob/ob mice. Moreover, whereas normal islets were pure white with a smooth surface, islets from POKO mice were gray; their surface was irregular and required less time for collagenase digestion (only ten minutes instead of 30 minutes), suggesting that they were also more fragile.
###end p 25
###begin p 26
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g003">Figure 3</xref>
###xml 267 275 267 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g003">Figure 3</xref>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
Insulin content in islets from ob/ob mice was more than 30-fold greater than in those from POKO mice (Figure 3B). Insulin secretion from the islets of POKO mice was strikingly impaired compared to those of ob/ob mice, even when expressed relative to insulin content (Figure 3C). This was observed under basal (1 mM glucose) and stimulated (16 mM glucose, 16 mM glucose + tolbutamide) release.
###end p 26
###begin title 27
###xml 28 32 <span type="species:ncbi:10090">Mice</span>
###xml 51 55 <span type="species:ncbi:10090">Mice</span>
Decreased Steatosis in POKO Mice Compared to Ob/Ob Mice
###end title 27
###begin p 28
###xml 99 107 99 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-st001">Table S1</xref>
###xml 196 204 196 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g003">Figure 3</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 189 194 <span type="species:ncbi:10090">mouse</span>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
As expected, the POKO mice had increased hepatic fat deposition compared to WT and PPARg2 KO mice (Table S1), but surprisingly the POKO mouse had much milder hepatosteatosis than the ob/ob mouse (Figure 3D), suggesting that ectopic expression of the PPARg2 isoform in the liver of ob/ob mice (see below), might contribute to the deposition of TAGs in the liver.
###end p 28
###begin title 29
Ablation of PPARg2 Induces a Lipotoxic Lipid Profile in Adipose Tissue, Pancreatic Islets, Liver, and Skeletal Muscle
###end title 29
###begin p 30
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b032">32</xref>
###xml 278 289 278 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
To investigate lipotoxicity as a potential pathogenic mechanism we used liquid chromatography/mass spectrometry (LC/MS) [32] to compare a broad spectrum of cellular lipids in the adipose tissue, pancreatic islets, liver, and skeletal muscle between the POKO mouse and controls (Protocol S1).
###end p 30
###begin title 31
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Adipose tissue from POKO mice has decreased TAG but increased DAG, ceramides, and other reactive lipid species associated with insulin resistance.
###end title 31
###begin p 32
###xml 115 126 115 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 214 225 214 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 495 506 495 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b033">33</xref>
###xml 813 824 813 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b034">34</xref>
###xml 995 1003 995 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g004">Figure 4</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
Lipidomic analysis using LC/MS identified 74 molecular species differentially present in POKO, ob/ob, and WT mice (Protocol S1). POKO adipose tissue had decreased short chain TAGs compared to ob/ob adipose tissue (Protocol S1). Conversely, the concentration of DAGs was increased in the WAT of the POKO mice compared to ob/ob littermates. There was also an increased concentration of reactive lipid species in the WAT of POKO mice compared to that of ob/ob. The WAT of both POKO and ob/ob mice (Protocol S1) had increased levels of two ceramide species (with 16:0 and 24:1 fatty acid chains, respectively) and three proinflammatory lysophosphatidylcholine species [33] compared to WT mice. Partial least squares discriminant analysis indicated these changes in ceramides were greater in the POKO than ob/ob mice (Protocol S1). Sphingomyelin (d18:1/16:0), the precursor of ceramide (d18:1/16:0) and antioxidant ethanolamine plasmalogen (36:1) [34] were markedly decreased in POKO and ob/ob mice (Figure 4A).
###end p 32
###begin title 33
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Decreased TAG and accumulation of reactive lipid species in islets from POKO mice.
###end title 33
###begin p 34
###xml 217 228 217 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 602 610 602 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g005">Figure 5</xref>
###xml 616 627 616 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:10090">mice</span>
Partial least-squares discriminant analysis of lipidomic profiles of isolated pancreatic islets of 16-week-old mice identified 44 lipid species accumulated at different concentrations in WT, PPARg2 KO, and POKO mice (Protocol S1). Short chain TAGs were decreased in islets from POKO and PPARg2 KO mice when compared to those from WT. This was associated with up-regulation of phosphatidylethanolamine (36:2), down-regulation of ethanolamine plasmalogen (36:2), and preferential accumulation of reactive lipid species, particularly of two ceramides (20:0 and 22:0 fatty acids) in islets from POKO mice (Figure 5A and Protocol S1).
###end p 34
###begin title 35
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Decreased TAG and increased reactive lipid species in liver of POKO mice.
###end title 35
###begin p 36
###xml 141 152 141 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 228 236 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g005">Figure 5</xref>
###xml 382 393 382 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b035">35</xref>
###xml 660 671 660 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
Multivariate analysis of lipidomic profiles (192 lipid species) revealed large changes between the POKO, PPARg2 KO, ob/ob, and WT genotypes (Protocol S1). These included decreased levels of short and medium chain TAGs and DAGs (Figure 5B) in livers from POKO mice compared to those of ob/ob mice. Livers from POKO mice also had decrease levels of phosphatidylcholine lipid species (Protocol S1) utilised during the formation and secretion of very low density lipoproteins [35]. Conversely, POKO livers were enriched in ceramides compared to ob/ob livers, which correlated with the extent of increased levels of lysophosphatidylcholines in POKO and ob/ob mice (Protocol S1).
###end p 36
###begin title 37
Decreased TAG and accumulation of reactive lipid species in POKO skeletal muscle.
###end title 37
###begin p 38
###xml 207 218 204 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 408 419 405 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
The same lipidomic pattern of decreased TAG and increased reactive lipid species previously observed in adipose tissue, beta-cell, and liver was found to a milder degree in the skeletal muscle of POKO mice (Protocol S1). Briefly, when compared to ob/ob skeletal muscle, POKO skeletal muscle showed a decrease in very short-chain fatty acid TAGs and a slight decrease in levels of medium and long chain TAGs (Protocol S1). The skeletal muscle of POKO mice also had increased reactive lipids including ceramide (d18:1/18:0), DAGs, lysophosphatidylcholines, and sphingomyelins (precursors of ceramides) when compared to that of ob/ob mice.
###end p 38
###begin title 39
###xml 32 36 <span type="species:ncbi:10090">Mice</span>
Transcriptomic Analysis in POKO Mice Correlates with Lipidomic Changes
###end title 39
###begin p 40
###xml 228 236 228 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-st004">Table S4</xref>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Given the lipotoxic profiles identified in the POKO mouse, we hypothesised changes in the expression of metabolic genes directly related to PPARg2 ablation and also compensatory changes in genes associated with cellular stress (Table S4).
###end p 40
###begin title 41
Gene expression analysis in WAT.
###end title 41
###begin p 42
###xml 30 50 30 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glut4, adipsin, aP2,</italic>
###xml 55 66 55 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">adiponectin</italic>
###xml 171 180 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg001">Figure S1</xref>
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g004">Figure 4</xref>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
Target genes of PPARg such as Glut4, adipsin, aP2, and adiponectin were decreased to a larger extent in the WAT of five- and 16-week-old POKO mice than in PPARg2 KO mice (Figure S1 and Figure 4B). At five weeks of age, when differences in body fat between female WT, ob/ob, and POKO mice are only starting to become evident, levels of GLUT4, aP2, and adiponectin mRNA levels were similar in WT and ob/ob mice, yet were markedly decreased in POKO mice. As the ob/ob mice aged (16 wk) and became obese and insulin resistant, the expression pattern of these PPARg targets in the WAT of ob/ob mice became similar to that of the POKO mice.
###end p 42
###begin p 43
###xml 117 125 117 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g004">Figure 4</xref>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Scd1)</italic>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 985 989 <span type="species:ncbi:10090">mice</span>
Results from the lipidomic analysis suggested major changes in the expression of genes involved in lipid metabolism (Figure 4B). Expression of stearoyl-coenzyme A desaturase 1 (Scd1) and sterol regulatory element-binding protein-1c (SREBP1c) were significantly lower in WAT from POKO mice compared to ob/ob mice. Furthermore, the decrease in TAGs and increased DAGs correlated with decreased expression of DAG acyltransferase 2, a key enzyme catalysing the final step in TAG synthesis, in the WAT of POKO mice compared with WAT from ob/ob mice. Again supporting the lipidomic profile, the expression of hormone-sensitive lipase, a rate-limiting enzyme for hydrolysis of diacylglycerides, was decreased in the WAT of POKO, PPARg2 KO, and ob/ob mice compared with WT mice, with the lowest levels observed in the POKO mice. Adipose triglyceride lipase levels were decreased in ob/ob and POKO compared with WT and PPARg2 KO mice, but without significant differences between ob/ob and POKO mice.
###end p 43
###begin p 44
###xml 444 452 444 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-st002">Table S2</xref>
###xml 723 731 723 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g004">Figure 4</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 930 935 <span type="species:ncbi:10090">mouse</span>
###xml 958 963 <span type="species:ncbi:10090">mouse</span>
Oxidative stress has recently been suggested as a common mechanism of insulin resistance. Adipose tissue from POKO mice had increased oxidative stress compared to that of ob/ob mice as indicated by decreased gene expression levels of extracellular CuZn-superoxide dismutase, disruption of the glutathione pathway as indicated by decreased levels of gluthatione synthase, and increased levels of peroxidase and several gluthatione transferases (Table S2). We examined macrophage infiltration of adipose tissue as a potential marker of inflammation associated insulin resistance. Expression of CD68 and F4/80, both macrophage markers, was increased in the WAT of both POKO and ob/ob mice compared with WT and PPARg2 KO mice (Figure 4B). However their expression levels were lower in the POKO mice than the ob/ob mice suggesting that macrophage infiltration was not directly related to the exacerbated insulin resistance of the POKO mouse compared to the ob/ob mouse.
###end p 44
###begin title 45
Gene expression in the POKO liver.
###end title 45
###begin p 46
###xml 262 270 262 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g005">Figure 5</xref>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scd1,</italic>
###xml 609 612 609 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lpl</italic>
###xml 788 811 785 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pparg, Lcad, Aox, Cpt1,</italic>
###xml 816 820 813 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 1007 1009 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b036">36</xref>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
Reduced hepatic steatosis accompanied by altered lipid profiles suggested that lack of hepatic ectopic expression of PPARg2 might be affecting lipid storage and metabolism in the liver of the POKO mice. Expression of genes involved in lipid metabolism in liver (Figure 5C) revealed that, proportional to the accumulation of TAGs in the liver, fatty acid synthase, Scd1, and the fatty acid translocase (FAT/CD36) were increased in ob/ob and POKO livers compared to WT mice and were significantly decreased in liver from POKO mice compared with liver from ob/ob mice. Other lipogenic PPARg target genes such as Lpl were also decreased in the POKO liver compared to the ob/ob mice. The ob/ob mice also had a compensatory increase in the expression of genes involved in beta-oxidation (e.g., Pparg, Lcad, Aox, Cpt1, and Ucp2). Interestingly expression of these pro-oxidative genes was decreased in the liver of POKO mice when compared to that of ob/ob mice suggesting PPARg2 may contribute to their regulation [36].
###end p 46
###begin p 47
###xml 394 396 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b037">37</xref>
###xml 559 567 556 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Pepck1)</italic>
###xml 594 600 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(G6pc)</italic>
###xml 666 674 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-st002">Table S2</xref>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
Although beta-cell failure could account for the severe hyperglycaemia observed in the POKO genotype, hepatic gluconeogenesis function might be affected. We observed a robust up-regulation of PPARg coactivator 1 alpha (PPARGC1a, also known as PGC1a) expression in the POKO liver compared with the WT and ob/ob mice. PPARGC1a is up-regulated in fasting and is thought to induce gluconeogenesis [37]. In parallel with the increase in PPARGC1a, microarray analysis revealed increased mRNA levels of the progluconeogenic genes phosphoenolpyruvate carboxykinase 1 (Pepck1) and glucose-6-phosphatase (G6pc) in the livers of POKO mice when compared to those of ob/ob mice (Table S2), suggesting hepatic gluconeogenesis may contribute to the hyperglycaemia observed in POKO mice.
###end p 47
###begin title 48
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Gene expression analysis in skeletal muscle of POKO mice.
###end title 48
###begin p 49
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Srebp1c</italic>
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppargc1a</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ucp2</italic>
###xml 218 221 218 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lpl</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Scd1</italic>
###xml 327 336 327 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sg005">Figure S5</xref>
###xml 338 346 338 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-st002">Table S2</xref>
###xml 613 621 613 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-st003">Table S3</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
In 16-week-old POKO-mice skeletal muscle we observed down-regulation of Srebp1c and Ppargc1a and up-regulation of Ucp2 expression in skeletal muscle from POKO mice compared to that of WT mice. Similarly, expression of Lpl and Scd1 was down-regulated in the skeletal muscle of POKO mice when compared with that from ob/ob mice (Figure S5; Table S2). Gene set enrichment analysis of microarray data showed decreased expression of oxidative phosphorylation and mitochondrial components including electron transport chain complex components, in skeletal muscle from POKO mice when compared with that from ob/ob mice (Table S3).
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
The link between obesity, insulin resistance, and diabetes while epidemiologically very clear is still not properly understood at a mechanistic level. An emerging concept is that the absolute amount of fat stored may be less important than the remaining storage capacity of the adipose tissue. Here we show that the PPARg2 isoform may be an important factor controlling obesity-induced comorbidities through two mechanisms: (a) by regulating nutritionally induced adipose tissue expandability and (b) when de novo expressed in nonadipose tissues, by allowing the storage of energy in the form of relatively harmless TAG species.
###end p 51
###begin p 52
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b017">17</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b020">20</xref>
###xml 663 666 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 670 672 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
###xml 702 707 <span type="species:ncbi:10090">mouse</span>
###xml 826 831 <span type="species:ncbi:10090">mouse</span>
###xml 883 888 <span type="species:ncbi:10090">mouse</span>
Previously we described the metabolic phenotype of the adult PPARg2 KO mouse [2], characterised by mild insulin resistance observed only in males. Given the greater adipogenic potency of PPARg2 compared with PPARg1 in vitro, we expected PPARg2 KO mice to have many more severe defects in adipose tissue than we observed, and therefore insulin sensitivity. As PPARg2 is the PPARg isoform regulated in response to nutrition and obesity [17-20], we hypothesised that PPARg2 would only become essential for adipose tissue function in the face of positive energy balance. The metabolic challenge we opted for was PPARg2 ablation in the obese (ob/ob) background (PPARg2-/- Lepob/Lepob, POKO mouse). The POKO mouse had severely decreased body-fat mass due to impaired adipose tissue expandability. Despite eating as much as an ob/ob mouse and expending a similar amount of energy, the POKO mouse was unable to store fat efficiently in its adipose tissue. This mismatch between increased energy availability and lack of adipose tissue expandability lead to a global metabolic failure characterised by severe insulin resistance, beta-cell failure, and dyslipidaemia.
###end p 52
###begin p 53
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b038">38</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b039">39</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b038">38</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b040">40</xref>
###xml 1224 1231 1224 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(P465L)</italic>
###xml 1265 1267 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b041">41</xref>
###xml 1620 1622 1620 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b019">19</xref>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 972 977 <span type="species:ncbi:10090">mouse</span>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
###xml 1184 1190 <span type="species:ncbi:10090">murine</span>
###xml 1209 1214 <span type="species:ncbi:9606">human</span>
###xml 1276 1280 <span type="species:ncbi:10090">mice</span>
###xml 1392 1398 <span type="species:ncbi:9606">humans</span>
###xml 1853 1858 <span type="species:ncbi:10090">mouse</span>
###xml 1892 1897 <span type="species:ncbi:10090">mouse</span>
###xml 1956 1960 <span type="species:ncbi:10090">mice</span>
###xml 2012 2016 <span type="species:ncbi:10090">mice</span>
The observation of reduced fat mass and increased insulin resistance in the POKO mouse compared to the ob/ob mouse strongly supports two of our hypotheses. First, we hypothesised that PPARg2 is required to recruit new adipocytes in overnutrition, but it is not required to make adipocytes during development. This is reflected by similar expression of aP2, a late marker of adipocyte differentiation, in POKO and ob/ob mice. The absence of small adipocytes was markedly different to other forms of lipodystrophy [38,39]. Additionally, and again in contrast with other lipodystrophic models that have markedly less adipose tissue than WT controls [38-40], the POKO mice had a percentage body fat that was similar (only 4% more) to WT and PPARg2 KO mice, as opposed to ob/ob mice, which had 40% fat as a proportion of body mass. This suggests that the remaining PPARg1 isoform is sufficient to support development of adipose tissue and fat deposition requirements of a lean mouse model. However, under conditions of positive energy balance, adipose tissue expandability mainly relies on the PPARg2 isoform. This idea is also suggested by the studies in heterozygous mice harbouring the murine equivalent of the human mutation (P465L) in PPARg on an ob/ob background [41]. These mice were able to accumulate fat and become obese even though showing a body mass 14% lower than ob/ob controls. In humans there is also evidence for a role for PPARg2. We have observed that metabolically healthy, nondiabetic, morbidly obese individuals have elevated levels of PPARg2 in their adipose tissue when compared to lean individuals [19]. Our second hypothesis, that the mismatch between energy availability and adipose tissue expandability is more important than fat mass itself as a predictor of insulin resistance, is also supported by our data. In fact the ob/ob mouse is much more obese than the POKO mouse but is much less insulin resistant. Furthermore, the POKO mice were already more insulin resistant than the ob/ob mice by the age of four weeks, with very low levels of GLUT4 in adipose tissue, before large differences in body weight developed, suggesting that the bioenergetic mismatch rather than the total amount of fat stored is important for the development of insulin resistance.
###end p 53
###begin p 54
###xml 491 493 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b042">42</xref>
###xml 494 496 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b043">43</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
Although we hypothesised that the POKO mice would become insulin resistant, the degree of hyperglycaemia in these animals was in excess of what we expected. We found that the normal adaptive response of beta-cells to insulin resistance did not occur in the POKO mice as indicated by the pathological changes observed by histology and the lack of beta-cell hypertrophy. Although it has been shown that genetic background can affect the ability of ob/ob mice to undergo beta-cell hypertrophy [42,43], we found that the ob/ob controls on our mixed 129Sv x C57BL/6J background underwent adaptive beta-cell hyperplasia and hypertrophy, suggesting that the lack of PPARg2 was responsible for the failure of the POKO beta-cells to adapt to insulin resistance. Interestingly the mass of pancreatic islets in POKO mice remained similar to the noninsulin resistant WT and PPARg2 KO mice. Furthermore, these defects in POKO beta-cells did not appear to be the result of a developmental defect, as new born and four-week-old mice had morphologically normal islets.
###end p 54
###begin p 55
###xml 156 158 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b030">30</xref>
###xml 1178 1180 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b044">44</xref>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 939 945 <span type="species:ncbi:9606">humans</span>
The severe beta-cell phenotype of the POKO mouse contrasts with the absence of hyperglycaemia observed in the pancreatic beta-cell specific PPARg KO mouse [30]. However it should be kept in mind that in the beta-cell specific PPARg KO mouse, the expression of PPARg and the lipid storage capacity of other tissues, most importantly adipose tissue, were not affected, and that insulin sensitivity was only mildly affected by high fat feeding in these mice when compared to the severe insulin resistance observed in POKO mice. Therefore the challenge to the pancreatic beta-cells in this model was milder than in POKO mice. This is a clear example of how tissue-specific genetic manipulations are not always the best approach to understand the physiology of an organ in the context of the global energy homeostasis. The potential importance of the de novo expression of PPARg2 isoform in beta-cells is also supported by the observation that humans harbouring the Pro12Ala mutation in PPARg2, a mutation that is located in the g2 isoform and makes PPARg2 less active, has only been associated with insulin deficiency and disease severity in obese individuals with type 2 diabetes [44].
###end p 55
###begin p 56
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
The liver of the POKO mouse also displayed an unusual phenotype. We expected the POKO mice to have worse hepatosteatosis with increased triglyceride deposition in liver compared to ob/ob mice, because the POKO mice could not store fat in adipose tissue. However POKO mice had less hepatosteatosis than ob/ob mice suggesting that the PPARg2 isoform may directly contribute to facilitate triglyceride deposition in the liver.
###end p 56
###begin p 57
###xml 714 716 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b045">45</xref>
###xml 717 719 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b049">49</xref>
###xml 909 911 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b050">50</xref>
###xml 912 914 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b052">52</xref>
###xml 305 310 <span type="species:ncbi:10090">mouse</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
A common mechanistic link for the phenotypes observed in the POKO liver and beta-cell was not immediately obvious. To try to determine the role of PPARg2 in these locations we performed lipidomic and gene expression analyses of the adipose tissue, pancreatic islet, liver, and skeletal muscle of the POKO mouse. The lipid pattern of adipose tissue from POKO mice was characterised by decreased TAGs and increased DAGs in parallel with decreased gene expression of DGAT2, hormone-sensitive lipase, and adipose triglyceride lipase. This decrease in TAGs in the POKO adipose tissue was associated with increased levels of reactive lipid species and a gene expression profile suggestive of increased oxidative stress [45-49]. Although it has been described that oxidative stress and insulin resistance may be related to infiltration of adipose tissue by macrophages, resulting in a chronic state of inflammation [50-52], we did not observe increased macrophage infiltration in the adipose tissue of POKO mice compared to that of ob/ob mice.
###end p 57
###begin p 58
###xml 695 703 692 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppargc1a</italic>
###xml 890 892 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b053">53</xref>
###xml 893 895 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b054">54</xref>
###xml 457 461 <span type="species:ncbi:10090">mice</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 884 888 <span type="species:ncbi:10090">mice</span>
Lipidomic analysis of POKO derived islets also showed decreased levels of triacyl and DAGs and increased levels of ceramides, suggesting that PPARg2 may contribute to increasing the lipid-buffering capacity of beta-cells by promoting formation of TAGs and thus preventing lipotoxic insults. Liver and skeletal muscle lipidomics also showed reduced TAG and increased formation of reactive lipid species such as ceramides and lysophosphatidylcholines in POKO mice compared to ob/ob mice. This lipid profile was associated with impaired expression of pathways controlling de novo lipogenesis, transport of fatty acids, and beta oxidation in the POKO mice compared with the ob/ob mice. Of interest, Ppargc1a and other gluconeogenic genes were induced in the liver of POKO mice compared to that of ob/ob mice, suggesting a potential mechanism contributing to marked hyperglycaemia in POKO mice [53,54].
###end p 58
###begin p 59
###xml 1769 1777 1763 1771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030064-g006">Figure 6</xref>
###xml 190 195 <span type="species:ncbi:10090">mouse</span>
###xml 218 223 <span type="species:ncbi:10090">mouse</span>
###xml 281 286 <span type="species:ncbi:10090">mouse</span>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
###xml 897 901 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
###xml 1223 1227 <span type="species:ncbi:10090">mice</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
###xml 1344 1349 <span type="species:ncbi:10090">mouse</span>
###xml 1435 1439 <span type="species:ncbi:10090">mice</span>
###xml 1680 1685 <span type="species:ncbi:10090">mouse</span>
Overall, our lipidomic studies identify a remarkably similar pattern of changes in lipid species in the four tissues studied. The reduced adipose tissue mass and hepatosteatosis in the POKO mouse compared to the ob/ob mouse is explained by reduced levels of mature TAG in the POKO mouse. Similarly, ablation of PPARg2 resulted in accumulation of reactive lipid species implicated in causing insulin resistance, not only in adipose tissue, but also in other organs involved in whole-organism glucose metabolism. These results indicate that expression of PPARg2 in the pancreas, liver, and muscle of the ob/ob mouse may be performing a protective role, by increasing the capacity of these organs to buffer toxic lipid species by allowing accumulation of relatively harmless TAGs. The importance of this peripheral antilipotoxic role of PPARg2 becomes more evident if we consider that POKO and ob/ob mice are under the same degree of positive energy balance as determined by similar food intake, locomotor activity, and energy expenditure, that both models lack leptin, and that the only difference between ob/ob and POKO mice is the presence or absence of PPARg2. Given the decreased adipose tissue expandability of the POKO mice compared to ob/ob, it was anticipated that, as in the liver, muscle, or beta-cells of lipodistrophic mice, the POKO mouse would accumulate more fat than the ob/ob. However, our results clearly indicate that mice lacking PPARg2, despite massive nutrient availability, are unable to deposit TAG in peripheral tissues and instead accumulate reactive lipid species in these organs. Therefore the pathologies of the liver and beta-cell observed in the POKO mouse may be a result of a common lipotoxic insult facilitated by the absence of PPARg2 (Figure 6).
###end p 59
###begin p 60
###xml 782 788 <span type="species:ncbi:9606">humans</span>
In summary, in this study we provide new insights into the physiological relevance of the PPARg2 isoform and identify adipose tissue expandability as an important determinant of metabolic complications. Ablation of PPARg2 decreases adipose tissue expandability, but its pathophysiological effects only become relevant in the context of a mismatch between energy availability and adipose tissue expansion. We show that PPARg2 also plays protective role when expressed de novo in peripheral organs by increasing their capacity to buffer toxic lipids. Ablation of PPARg2 under conditions of positive energy balance determined by absence of leptin produced early development of severe insulin resistance, beta-cell failure, diabetes, and hyperlipidaemia. Extrapolation of this model to humans may suggest that normal to overweight individuals with positive energy balance and inappropriately severe manifestations of the MS may have a defect in PPARg2 and/or alternative mechanisms that control adipose tissue expandability.
###end p 60
###begin title 61
Materials and Methods
###end title 61
###begin title 62
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Generation of mice homozygous for PPARg2 KO and leptin deficiency (ob/ob).
###end title 62
###begin p 63
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 135 137 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 141 142 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 267 270 267 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 274 276 274 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 361 364 361 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 373 374 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 402 403 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 424 427 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 431 433 431 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 437 439 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 458 461 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 465 467 465 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 471 473 471 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob</sup>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b055">55</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
Mice heterozygous for a disruption in exon B1 of PPARg2 on a 129Sv background (PPARg2+/-) [2] were crossed with heterozygous ob/ob (Lepob/Lep+) mice on a C57Bl/6 background to obtain mice heterozygous for both the PPARg2 ablation and the leptin point mutation (PPARg2+/- Lepob/Lep+). These mice were crossed to obtain the four experimental genotypes: WT (PPARg2+/+ Lep+/Lep+), PPARg2 KO (PPARg2-/- Lep +/Lep+), ob/ob (PPARg2+/+ Lepob/Lepob), and POKO (PPARg2-/- Lepob/Lepob). Genotyping for deletion of PPARg2 and the point mutation in the ob gene was performed by PCR using standard protocols [2,55].
###end p 63
###begin title 64
Animal care.
###end title 64
###begin p 65
Animals were housed at a density of four animals per cage in a temperature-controlled room (20-22 degreesC) with 12-h light/dark cycles. Food and water were available ad libitum unless noted. All animal protocols used in this study were approved by the UK Home Office and the University of Cambridge.
###end p 65
###begin title 66
Blood and urine biochemistry, food intake, and body composition analysis.
###end title 66
###begin p 67
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice of the four experimental genotypes were placed at weaning (three weeks of age) on a normal chow diet (10% of calories derived from fat; D12450B, Research Diets, ). Enzymatic assay kits were used for determination of plasma FFAs (Roche, ) and TAGs (Sigma-Aldrich, ). Elisa kits were used for measurements of leptin (R & D Systems, ), insulin (DRG Diagnostics International Limited, ), and adiponectin (B-Bridge International, ) according to manufacturers' instructions. Dual-energy X-ray absorptiometry (DEXA, Lunar Corporation, ) was used to measure body composition; glucose in blood and in urine and food intake were monitored in the four experimental genotypes as previously shown [2].
###end p 67
###begin title 68
Oxygen consumption, water intake, and locomotor activity.
###end title 68
###begin p 69
###xml 475 476 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 500 501 494 495 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 556 557 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 564 565 558 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 257 261 <span type="species:ncbi:10090">Mice</span>
###xml 575 579 <span type="species:ncbi:10090">Mice</span>
###xml 651 655 <span type="species:ncbi:10090">Mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
Oxygen was measured using an eight-chamber open-circuit oxygen-monitoring system attached to and sampled from the chambers of a Comprehensive Laboratory Animal Monitoring System (CLAMS; Columbus Instruments, ). Water consumed was also measured using CLAMS. Mice were housed individually in specially built Plexiglass cages maintained at 22 degreesC under an alternating 12:12-h light-dark cycle (light period 08:00-20:00). Sample air was sequentially passed through oxygen (O2) and carbon dioxide (CO2) sensors (Columbus Instruments) for determination of O2 and CO2 content. Mice were acclimatized to monitoring cages for 72 h before data collection. Mice were weighed before each trial. Ambulatory activity of individually housed mice was evaluated using an eight-cage rack OPTO-M3 Sensor system (Columbus Instruments). Cumulative ambulatory activity counts were recorded every 5 min throughout the light and dark cycles.
###end p 69
###begin title 70
Calculations of energy lost in urine.
###end title 70
###begin p 71
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b056">56</xref>
Energy lost in urine was calculated accordingly as previously shown before [56] using the following calculations:
###end p 71
###begin p 72
###xml 134 138 134 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">carb</sub>
###xml 149 153 149 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">carb</sub>
Energy lost in urine kJ/day = (glucose in urine [mMol/l]/1,000) x molecular weight glucose x (water intake [ml/day]/1,000) x E densitycarb; E densitycarb = energy density related to oxidations within the body for carbohydrates as glucose = 15.76 kJ/g.
###end p 72
###begin title 73
RNA preparation and real-time quantitative RT-PCR.
###end title 73
###begin p 74
Total RNA was isolated from islets and tissues samples according to the manufacturer's instructions (RNAeasy kit, Qiagen, ) and STAT60 (Tel-Test, ). Real-time quantitative PCR was performed using a TaqMan 7900 (Applied Biosystems, ) according to standard protocols.
###end p 74
###begin title 75
Western blot analyses.
###end title 75
###begin p 76
The tissue samples (40 mug) were subjected to SDS-PAGE on 8% polyacrylamide gels. Proteins were then electrophoretically transferred to polyvinylidene difluoride filters. After transferring, the filters were blocked with 5% nonfat dry milk in TBS-Tween 20 followed by incubation with primary GLUT4 and extracellular signal-regulated kinase 1/2 (ERK1/2) antibodies (Promega, ) overnight. The bands were quantified by scanning densitometry.
###end p 76
###begin title 77
Light microscopy and immunohistochemcal analysis.
###end title 77
###begin p 78
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b057">57</xref>
Tissue samples for morphological and immunohistochemcal analysis were prepared according to published protocols [2]. Morphometric analyses of adipose tissue and pancreas sections were acquired using a digital camera and microscope (Olympus BX41, ), and cell areas were measured using AnalySIS software (Soft Imaging System, ). For adipose tissue, two fields from each section were analysed to obtain the mean cell-area per animal (n = 5 per genotype). The Computer Assisted Stereology Toolbox (CAST) 2.0 system from Olympus was used to perform all measurements in the pancreas according to published protocols [57].
###end p 78
###begin title 79
Isolation and culture of pancreatic islets.
###end title 79
###begin p 80
###xml 307 308 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The pancreas was injected via the bile duct with cold Hank's solution containing 0.4% (w/v) liberase (Roche). The pancreas was removed, digested for 15-30 min, and islets collected by handpicking. Isolated islets were cultured overnight in h-cell medium (SBMI 06, hcell technology, ) at 37 degreesC in 5% CO2 in air. Islets were used the day after isolation for insulin secretion studies or RNA extraction.
###end p 80
###begin title 81
Insulin secretion studies.
###end title 81
###begin p 82
###xml 361 366 <span type="species:ncbi:10090">Mouse</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
Insulin secretion from isolated islets (five islets/well) was measured during 1-hr static incubations in Krebs-Ringer Buffer containing either 1 mM glucose, 16.7 mM glucose, or 16.7 mM glucose plus 200 muM tolbutamide in DMSO. The supernatants were assayed for insulin. Insulin content was extracted using 95:5 ethanol/acetic acid. Insulin was measured using a Mouse Insulin ELISA kit (Mercodia, ). Islets were isolated from three mice of each genotype for these experiments. Thus, the data are the mean of three separate experiments, in which data were collected for each test solution from six samples each of five islets. For each sample, insulin release was normalised to insulin content.
###end p 82
###begin title 83
ITT.
###end title 83
###begin p 84
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b058">58</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
ITTs on four-week-old mice were performed as previously published [58].
###end p 84
###begin title 85
Lipid profiling.
###end title 85
###begin p 86
###xml 215 216 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b002">2</xref>
For WAT and muscle, the tissue sample (50 mg) was homogenized with 0.15 M sodium chloride (300 mul), and the lipids were extracted with 2 ml of chloroform: methanol (2:1) and used for LC/MS as previously described [2].
###end p 86
###begin p 87
For liver and islets, an aliquot (20 mul for liver or 10 mul for islets) of an internal standard mixture (11 reference compounds at concentration level 8-10 mug/ml), 50 mul of 0.15 M sodium chloride (for liver), and chloroform:methanol (2:1) (200 mul for liver or 90 mul for islets) was added to the tissue sample (20-30 mg). The sample was homogenized, vortexed (2 min for liver or 15 s for islets), let to stand (1 h for liver, 20 min for islets), and centrifuged at 10,000 RPM for 3 min. From the separated lower phase, an aliquot was mixed with 10 mul of a labelled standard mixture (three stable isotope-labelled reference compounds at concentration level 9-11 mug/ml), and 0.5-1.0 mul injection was used for LC/MS analysis.
###end p 87
###begin p 88
###xml 321 322 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 411 412 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Total lipid extracts were analysed on a Waters Q-Tof Premier mass spectrometer () combined with an Acquity Ultra Performance LC (UPLC). The column, which was kept at 50 degreesC, was an Acquity UPLC BEH C18 10 x 50 mm with 1.7 mum particles. The binary solvent system (flow rate 0.200 ml/min) included A, water (1% 1 M NH4Ac, 0.1% HCOOH), and B, LC/MS grade (Rathburn, ) acetonitrile/isopropanol (5:2, 1% 1 M NH4Ac, 0.1% HCOOH). The gradient started from 65% A/35% B, reached 100% B in 6 min, and remained there for the next 7 min. The total run time per sample, including a 5 min re-equilibration step, was 18 min. The temperature of the sample organizer was set at 10 degreesC.
###end p 88
###begin p 89
Mass spectrometry was carried out on Q-Tof Premier (Waters) run in ESI+ mode. The data were collected over the mass range of m/z 300-1,200 with scan duration of 0.2 s. The source temperature was set at 120 degreesC, and nitrogen was used as desolvation gas (800 l/h) at 250 degreesC. The voltages of the sampling cone and capillary were 39 V and 3.2 kV, respectively. Reserpine (50 mug/l) was used as the lock spray reference compound (5 mul/min; 10 s-scan frequency).
###end p 89
###begin p 90
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030064-b059">59</xref>
Data processing was performed using the MZmine software [59]. Identification was performed based on an internal reference database of lipid species, or alternatively utilizing the tandem mass spectrometry. The statistical analyses were performed using Matlab (Mathworks, ) and the Matlab library PLS Toolbox (Eigenvector Research, ).
###end p 90
###begin p 91
###xml 246 257 246 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030064-sd001">Protocol S1</xref>
Tandem mass spectrometry was used for the identification of selected lipid species. MS/MS runs were performed by using ESI+ mode, collision energy ramp from 15-30 V, and mass range starting from m/z 150. The other conditions were as shown in the Protocol S1.
###end p 91
###begin title 92
Statistics.
###end title 92
###begin p 93
###xml 195 197 193 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
Results were expressed as mean +/- standard error of mean. Statistical analysis was performed using a two-tailed unpaired t-test between appropriate pairs of groups, and significance declared if p-values were less than 0.05.
###end p 93
###begin title 94
Supporting Information
###end title 94
###begin title 95
Adipose Tissue and Liver Gene Expression
###end title 95
###begin p 96
(39 KB PPT)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin title 98
Water Consumed and Locomotor Activity
###end title 98
###begin p 99
(38 KB PPT)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin title 101
GLUT4 protein expression in WAT
###end title 101
###begin p 102
(65 KB PPT)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin title 104
Gene Expression in Islets
###end title 104
###begin p 105
(25 KB PPT)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin title 107
Gene Expression in Muscle
###end title 107
###begin p 108
(32 KB PPT)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin title 110
###xml 5 10 <span type="species:ncbi:10090">Mouse</span>
POKO Mouse Model Lipidomics Dataset
###end title 110
###begin p 111
(208 KB PDF)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin title 113
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Tissue Weights of 16-Wk-Old Male POKO, Ob/Ob, PPARg2 KO, and WT mice
###end title 113
###begin p 114
(29 KB PPT)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin title 116
Microarray Data
###end title 116
###begin p 117
(105 KB DOC)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin title 119
Pathway Analysis from Microarray Data
###end title 119
###begin p 120
(112 KB XLS)
###end p 120
###begin p 121
Click here for additional data file.
###end p 121
###begin title 122
Accession Numbers
###end title 122
###begin p 123
GenBank () accession numbers for the genes and gene products discussed in this paper.
###end p 123
###begin p 124
(58 KB DOC)
###end p 124
###begin p 125
Click here for additional data file.
###end p 125
###begin p 126
###xml 99 106 <span type="species:ncbi:8058">Whiting</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
Animal care and husbandry provided by J. Carter, S. Shelton, H. Wetsby, H. Williams, A. Kant, J.P. Whiting, and G. Bevan. We thank D. Lam, M. Dale, and K. Burling for their technical assistance. We also thank J. Skepper and P.M. Coan for their help with morphometry analysis in pancreas and Peter Murgatroyd for his help with oxygen consumption experiments. We acknowledge Paradigm Therapeutics () for generating the PPARg2 KO mouse.
###end p 126
###begin title 127
Abbreviations
###end title 127
###begin p 128
diacylglycerol
###end p 128
###begin p 129
glucose transporter
###end p 129
###begin p 130
haematoxylin and eosin
###end p 130
###begin p 131
insulin tolerance test
###end p 131
###begin p 132
liquid chromatography/mass spectrometry
###end p 132
###begin p 133
Metabolic Syndrome
###end p 133
###begin p 134
peroxisome proliferator activated receptor gamma
###end p 134
###begin p 135
peroxisome proliferator activated receptor gamma 2
###end p 135
###begin p 136
PPARg coactivator 1 alpha
###end p 136
###begin p 137
stearoyl-coenzyme A desaturase 1
###end p 137
###begin p 138
triacylglycerol
###end p 138
###begin p 139
white adipose tissue
###end p 139
###begin p 140
wild type
###end p 140
###begin title 141
References
###end title 141
###begin article-title 142
Molecular regulation of adipogenesis
###end article-title 142
###begin article-title 143
The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform
###end article-title 143
###begin article-title 144
Inflammation: The link between insulin resistance, obesity and diabetes
###end article-title 144
###begin article-title 145
Inflammation, stress, and diabetes
###end article-title 145
###begin article-title 146
The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity
###end article-title 146
###begin article-title 147
Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation
###end article-title 147
###begin article-title 148
Minireview: Weapons of lean body mass destruction: The role of ectopic lipids in the metabolic syndrome
###end article-title 148
###begin article-title 149
Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
###end article-title 149
###begin article-title 150
###xml 95 99 <span type="species:ncbi:10116">rats</span>
Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-beta-cell relationships
###end article-title 150
###begin article-title 151
###xml 83 88 <span type="species:ncbi:9606">human</span>
Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated
###end article-title 151
###begin article-title 152
Lipoapoptosis: Its mechanism and its diseases
###end article-title 152
###begin article-title 153
PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
###end article-title 153
###begin article-title 154
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice
###end article-title 154
###begin article-title 155
PPAR gamma is required for placental, cardiac, and adipose tissue development
###end article-title 155
###begin article-title 156
PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
###end article-title 156
###begin article-title 157
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 42 45 <span type="species:ncbi:10116">rat</span>
Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding
###end article-title 157
###begin article-title 158
Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin
###end article-title 158
###begin article-title 159
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents
###end article-title 159
###begin article-title 160
###xml 62 67 <span type="species:ncbi:9606">human</span>
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids
###end article-title 160
###begin article-title 161
PPARgamma knockdown by engineered transcription factors: Exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis
###end article-title 161
###begin article-title 162
Selective disruption of PPAR{gamma}2 impairs the development of adipose tissue and insulin sensitivity
###end article-title 162
###begin article-title 163
Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle
###end article-title 163
###begin article-title 164
Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass
###end article-title 164
###begin article-title 165
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
###end article-title 165
###begin article-title 166
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones
###end article-title 166
###begin article-title 167
Muscle-specific Pparg deletion causes insulin resistance
###end article-title 167
###begin article-title 168
###xml 146 149 <span type="species:ncbi:10116">rat</span>
Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
###end article-title 168
###begin article-title 169
###xml 85 90 <span type="species:ncbi:9606">human</span>
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells
###end article-title 169
###begin article-title 170
Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition
###end article-title 170
###begin article-title 171
Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis
###end article-title 171
###begin article-title 172
###xml 182 186 <span type="species:ncbi:10090">mice</span>
Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet
###end article-title 172
###begin article-title 173
Metabolomic approaches to phenotype characterization and applications to complex diseases
###end article-title 173
###begin article-title 174
Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2
###end article-title 174
###begin article-title 175
Plasmalogens as endogenous antioxidants: Somatic cell mutants reveal the importance of the vinyl ether
###end article-title 175
###begin article-title 176
###xml 104 107 <span type="species:ncbi:10116">rat</span>
The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes
###end article-title 176
###begin article-title 177
Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression
###end article-title 177
###begin article-title 178
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction
###end article-title 178
###begin article-title 179
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
###end article-title 179
###begin article-title 180
###xml 55 70 <span type="species:ncbi:10090">Transgenic mice</span>
Targeted expression of a toxin gene to adipose tissue: Transgenic mice resistant to obesity
###end article-title 180
###begin article-title 181
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Life without white fat: A transgenic mouse
###end article-title 181
###begin article-title 182
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice
###end article-title 182
###begin article-title 183
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
Diabetes, a new mutation in the mouse
###end article-title 183
###begin article-title 184
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
The influence of genetic background on the expression of mutations at the diabetes locus in the mouse IV. Male lethal syndrome in CBA/Lt mice
###end article-title 184
###begin article-title 185
The Pro12 ->Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population: Possible involvement in impairment of insulin secretion in individuals with type 2 diabetes
###end article-title 185
###begin article-title 186
Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes
###end article-title 186
###begin article-title 187
N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: Possible role of oxidative stress
###end article-title 187
###begin article-title 188
Effect of thiol antioxidant on body fat and insulin reactivity
###end article-title 188
###begin article-title 189
Reactive species and early manifestation of insulin resistance in type 2 diabetes
###end article-title 189
###begin article-title 190
Proposed mechanisms for the induction of insulin resistance by oxidative stress
###end article-title 190
###begin article-title 191
Obesity is associated with macrophage accumulation in adipose tissue
###end article-title 191
###begin article-title 192
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
###end article-title 192
###begin article-title 193
Tumor necrosis factor-alpha-induced insulin resistance in adipocytes
###end article-title 193
###begin article-title 194
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
###end article-title 194
###begin article-title 195
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
###end article-title 195
###begin article-title 196
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Genetic typing of the mouse ob mutation by PCR and restriction enzyme analysis
###end article-title 196
###begin article-title 197
Energy expenditure and fuel selection in biological systems: The theory and practice of calculations based on indirect calorimetry and tracer methods
###end article-title 197
###begin article-title 198
Optimizing sampling efficiency of stereological studies in biology: Or 'do more less well!'
###end article-title 198
###begin article-title 199
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Energy metabolism in uncoupling protein 3 gene knockout mice
###end article-title 199
###begin article-title 200
Processing methods for differential analysis of LC/MS profile data
###end article-title 200
###begin title 201
Figures and Tables
###end title 201
###begin title 202
###xml 39 44 <span type="species:ncbi:10090">Mouse</span>
Physiological Characterisation of POKO Mouse
###end title 202
###begin p 203
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 212 213 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A) Body weights (black circles, WT; black squares, ob/ob; white circles, PPARg2 KO; white squares, POKO) are shown for males (left) or females (right) (n = 5-12). *, p < 0.05 POKO versus ob/ob and section sign, p < 0.01 POKO versus WT.
###end p 203
###begin p 204
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
(B) Food intake from 20-wk-old female mice (n = 4) is shown.
###end p 204
###begin p 205
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
(C) Body composition analysis from 20-wk-old females is shown: WT, ob/ob, PPARg2 KO, and POKO mice fed chow diet mice (n = 4-7). *, p < 0.05 POKO versus WT and ###, p < 0.001 POKO versus ob/ob.
###end p 205
###begin p 206
###xml 120 124 <span type="species:ncbi:10090">mice</span>
(D) Haematoxylin and eosin (H and E)-stained sections (10x) from epididymal WAT from 16-wk-old male WT, ob/ob, and POKO mice.
###end p 206
###begin p 207
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
(E) Percent relative cumulative frequency analysis (PRCF) from epididymal WAT adipocytes from 16-wk-old male WT, ob/ob, PPARg2 KO, and POKO mice. (n = 4-5).
###end p 207
###begin title 208
###xml 33 37 <span type="species:ncbi:10090">Mice</span>
Early Insulin Resistance in POKO Mice Independent of Body Weight
###end title 208
###begin p 209
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A) Body weight and plasma glucose levels from three, four, and five-week-old female WT, ob/ob, PPARg2 KO, and POKO. *, p < 0.05; **, p < 0.01; ***, p < 0.001 POKO versus ob/ob.
###end p 209
###begin p 210
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
(B) Plasma glucose levels during ITT on 4-wk-old male (left) and female (right) mice on chow diet (black triangle, WT; white triangle, PPARg2 KO; black square, ob/ob; black diamond, POKO) (n = 7). *, p < 0.05; **, p < 0.01 POKO versus ob/ob.
###end p 210
###begin p 211
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
(C) Morphological analysis of H and E-stained sections (10x) in pancreas from 4-wk-old males ob/ob and POKO mice (n = 5).
###end p 211
###begin title 212
###xml 74 78 <span type="species:ncbi:10090">Mice</span>
Impaired beta-Cell Function and Hepatic Morphological Analyis in the POKO Mice
###end title 212
###begin p 213
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
(A) H and E-stained sections (10x) and immunohistochemical (20x) analysis of insulin and glucagon in pancreas from 16-wk-old males WT, ob/ob, and POKO mice (n = 5).
###end p 213
###begin p 214
###xml 154 154 154 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
(B) Insulin content of islets isolated from POKO (black bars), and ob/ob (grey bars) mice. Each data point is the mean of six samples each of five islets.
###end p 214
###begin p 215
###xml 331 332 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 345 346 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 360 361 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
(C) Insulin secretion from islets isolated from POKO (black bars) and ob/ob (grey bars) mice in response to glucose (1, 16 mM) or glucose 16 mM + tolbutamide (200 muM). Data were collected from six samples each of five islets from three mice of each genotype. For each sample, insulin release was normalised to insulin content. *, p < 0.05; **, p < 0.01; ***, p < 0.001 POKO versus ob/ob.
###end p 215
###begin p 216
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
(D) H and E-stained sections (4x) in liver from 16-wk-old males WT, ob/ob, and POKO mice (n = 5).
###end p 216
###begin title 217
Lipidomic and Gene Expression Analysis of POKO WAT
###end title 217
###begin p 218
###xml 72 76 <span type="species:ncbi:10090">mice</span>
(A) Lipidomic profiling of WAT from 16-wk-old males WT, ob/ob, and POKO mice.
###end p 218
###begin p 219
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 150 151 150 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
(B) Adipose tissue mRNA levels from different genes from 16-wk-old male WT, PPARg2 KO, ob/ob, and POKO mice (n = 6-8). *, p < 0.05; **, p <0.01; ***, p <0.001 POKO versus ob/ob.
###end p 219
###begin title 220
###xml 69 73 <span type="species:ncbi:10090">Mice</span>
Lipidomic and Gene Expression Analysis in Islets and Liver from POKO Mice
###end title 220
###begin p 221
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
Lipidomic profiling of islets (A) and liver (B) from 16-wk-old males WT, PPARg2 KO, ob/ob, and POKO mice. TG, TAGs; DAGs, diacylglycerols; SM, sphingomyelins. (C) Liver gene expression from 16-wk-old male WT, ob/ob, PPARg2 KO, and POKO mice fed chow (n = 6-8). *, p < 0.05; **, p, <0.01; ***, p <0.001 POKO versus ob/ob; ###, p < 0.001 POKO versus WT; double daggerdouble daggerdouble dagger, p < 0.001 ob/ob versus WT.
###end p 221
###begin title 222
Storage of Lipids-Antilipotoxic Role of PPARg2
###end title 222
###begin p 223
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
Antilipotoxic role of PPARg2 mediated by (a) expansion of adipose tissue and facilitation of triglyceride deposition and (b) facilitating deposition of fat in liver, skeletal muscle, and pancreas in the form of TAG. Ob/Ob mice can induce PPARg2 expression in liver, muscle, and beta-cell, facilitating deposition of excess of energy in these organs in the form of TAG. Absence of inducibility of PPARg2 in POKO mouse liver, muscle, and beta-cells results in increased deposition of reactive lipid species and decreased TAG, leading to marked insulin resistance and beta-cell failure.
###end p 223
###begin p 224
###xml 84 88 <span type="species:ncbi:10090">Mice</span>
Metabolic Parameters in Fed 4-Wk-Old Male and Female POKO, Ob/Ob, PPARg2 KO, and WT Mice
###end p 224
###begin p 225
###xml 59 63 <span type="species:ncbi:10090">Mice</span>
Metabolic Parameters in 16-wk-Old Male POKO, Ob/Ob, and WT Mice
###end p 225
###begin p 226
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 226
###begin p 227
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. GMG, SLG, FMA, and AVP conceived and designed the experiments. GMG, SLG, LY, KS, SV, MB, ML, and MO performed the experiments. GMG, SLG, LY, KS, SV, MC, RKC, MJL, TSL, and MO analysed the data. GMG, LY, KS, SV, MC, RKC, MB, and GSHY contributed reagents/materials/analysis tools. GMG and AVP wrote the paper.
###end p 227
###begin p 228
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by the European Union FP6 Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (Hepadip) integrated program () (LSHM-CT-2005-018734); Diabetes UK; Medical Research Council; Wellcome Trust Integrative Physiology program; Academy of Finland (grant number 111338); and Marie Curie International Reintegration Grant from the European Community.
###end p 228

